Add your e-mail address to receive free newsletters from SCIRP.

A large new study suggests that tailoring breast cancer screening to a woman’s individual risk may be safer and more effective than relying on routine annual mammograms for everyone. By matching screening frequency to personal risk levels,…

A deadly, drug-resistant fungus, Candida auris, is spreading globally, with 7,000 US cases in 2025. Researchers warn of limited treatments but see hope in new studies targeting its biology.
ERBIL (Kurdistan24) — A deadly and…

It was a comeback year in 2025 in many ways, from the resurgence of ’90s fashion, such as bootcut jeans and denim-on-denim, to the return of wired headphones.
But 2025 also saw the revival of less desirable relics, like the measles, which…

AgenT-797 is an experimental cancer treatment being studied in clinical trials. It belongs to a newer category of treatments called cellular immunotherapy, which uses immune cells to help the body recognize and fight cancer….

Cellular immunotherapy has traditionally centered on autologous, genetically engineered T-cell platforms, which—despite transformative efficacy in selected settings—are limited by toxicity, manufacturing complexity, and…

Liver cancer treatment has evolved significantly over the past two decades, and tumor ablation has become an important option for selected patients—especially those diagnosed at an early stage. For many people who are not…

A crackdown on advertising for unhealthy food comes into full effect on Monday in a bid to tackle childhood obesity.
The ban prevents ads for “less healthy” food and drink that is high in fat, salt and sugar (HFSS) appearing on television…

Access to obesity treatment in the UK may be heading toward a two-tier system, raising concerns that some of the most vulnerable patients could be left without help. Researchers warn that people who cannot afford private care may struggle to…

A 22-year-old graduate student…